•Metformin may slow postoperative PCO•Lineage reports positive 36-month findings on GA cell therapy•Upsher-Smith launches Restasis generic to US market•Rain Eyecare launches dedicated dry eye telehealth platform •Viridian Therapeutics releases topline phase 3 TED data elegrobart•Metformin may slow postoperative PCO•Lineage reports positive 36-month findings on GA cell therapy•Upsher-Smith launches Restasis generic to US market•Rain Eyecare launches dedicated dry eye telehealth platform •Viridian Therapeutics releases topline phase 3 TED data elegrobart
HEADLINES
FEATURED
Decision follows company’s challenge to its third rejected package of ONS-5010 / LYTENAVA (bevacizumab-vikg); fourth submission expected in June.
Earn FREE CE 24/7 with Courses by Eyes On Eyecare
Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.
